Targeted next generation sequencing of clinically significant gene mutations and translocations in leukemia.

Abstract excerpt

Leukemias are currently subclassified based on the presence of recurrent cytogenetic abnormalities and gene mutations. These molecular findings are the basis for risk-adapted therapy; however, such data are generally obtained by disparate methods in the clinical laboratory, and often rely on low-resolution techniques such as fluorescent in situ hybridization. Using targeted next generation sequencing, we...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Databases, Genetic
• Share to Gene Expression Regulation, Neoplastic